Plain-English translation of NCT07384897 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand how your immune system cells behave in lung diseases like lung cancer, sarcoidosis, and COPD. By studying blood and tissue samples from patients with these conditions, alongside healthy volunteers, scientists hope to figure out why immunotherapy works well for some patients but not others—and use that knowledge to develop better, more personalized treatments.
Current immunotherapy treatments help only a small number of lung cancer patients, and doctors don't yet understand why some people respond while others don't or develop resistance. This research aims to fill that gap by studying immune cell behavior in detail.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be asked to provide blood samples and possibly tissue samples so researchers can examine your immune cells under the microscope. The study is observational, meaning researchers will study your samples in the laboratory rather than giving you a new medication to take. Depending on which group you're in, you may have one or more visits to provide samples, and researchers may review your medical records to understand your lung disease history.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Belgium